ESC 365 - Embolic stroke. Ischaemic and bleeding risk in patients undergoing TAVI.

ESC Professional Premium Access

Embolic stroke. Ischaemic and bleeding risk in patients undergoing TAVI.

Session: What you need to know about antithrombotic therapy in patients after TAVI

Topic: Clinical

Speaker: Professor D. Capodanno (Catania, IT)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Professor Davide Capodanno

University of Catania, Catania (Italy)

33 presentations

21 followers

4 more presentations in this session

Antithrombotic therapy in TAVI patients without indication for oral anticoagulation.

Speaker: Professor G. Dangas (New York, US)

Antithrombotic therapy in TAVI patients with indication for oral anticoagulation.

Speaker: Professor M. Valgimigli (Lugano, CH)

Antithrombotic therapy during TAVI and peri-interventional management of antithrombotic therapy.

Speaker: Doctor M. Joner (Munich, DE)

What you need to know about antithrombotic therapy in patients after TAVI – discussion.

Access the full session

What you need to know about antithrombotic therapy in patients after TAVI

Speakers: Professor D. Capodanno, Professor G. Dangas, Professor M. Valgimigli, Doctor M. Joner

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources